Article
Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation.
LGBT health - 1 Jan 2000
Wolf-Gould Carolyn S, Riley Moira R, Carswell Jeremi M
Abstract excerpt
The risks of being a cisgender BRCA1/BRCA2 mutation carrier (BRCA1+/BRCA2+) are well documented, and recommendations to mitigate cancer risk in BRCA+ cisgender women are clear. However, there is a lack of guidance for BRCA+ transgender women. In this article, we discuss the case of a trans-feminine youth who presented at a gender clinic for medications for pubertal suppression and was identified as a BRCA1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.